분자영상 및 방사화학

본문글자크기
  • 2017년 02월호
    [Theranostics.] Microbubble gas volume: A unifying dose parameter in blood-brain barrier opening by focused ultrasound.

    University of Colorado/ 송강호, Mark A. Borden*, Brandon K. Harvey*

  • 출처
    Theranostics.
  • 등재일
    2017 Jan 1
  • 저널이슈번호
    7(1):144-152. doi: 10.7150/thno.15987. eCollection 2017.
  • 내용

    바로가기  >

    Abstract

    Focused ultrasound with microbubbles is being developed to transiently, locally and noninvasively open the blood-brain barrier (BBB) for improved pharmaceutical delivery. Prior work has demonstrated that, for a given concentration dose, microbubble size affects both the intravascular circulation persistence and extent of BBB opening. When matched to gas volume dose, however, the circulation half-life was found to be independent of microbubble size. In order to determine whether this holds true for BBB opening as well, we independently measured the effects of microbubble size (2 vs. 6 µm diameter) and concentration, covering a range of overlapping gas volume doses (1-40 µL/kg). We first demonstrated precise targeting and a linear dose-response of Evans Blue dye extravasation to the rat striatum for a set of constant microbubble and ultrasound parameters. We found that dye extravasation increased linearly with gas volume dose, with data points from both microbubble sizes collapsing to a single line. A linear trend was observed for both the initial sonication (R2=0.90) and a second sonication on the contralateral side (R2=0.68). Based on these results, we conclude that microbubble gas volume dose, not size, determines the extent of BBB opening by focused ultrasound (1 MHz, ~0.5 MPa at the focus). This result may simplify planning for focused ultrasound treatments by constraining the protocol to a single microbubble parameter - gas volume dose - which gives equivalent results for varying size distributions. Finally, using optimal parameters determined for Evan Blue, we demonstrated gene delivery and expression using a viral vector, dsAAV1-CMV-EGFP, one week after BBB disruption, which allowed us to qualitatively evaluate neuronal health.


    Author information

    Song KH1, Fan AC1, Hinkle JJ2, Newman J2, Borden MA3, Harvey BK2.

    1Department of Mechanical Engineering, University of Colorado, Boulder, CO 80309.; Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, 21224.

    2Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, 21224.

    3Department of Mechanical Engineering, University of Colorado, Boulder, CO 80309. 

  • 키워드
    drug delivery; gene therapy; pharmacokinetics.; ultrasound contrast agent
  • 덧글달기
    덧글달기
       IP : 13.58.244.216

    등록